Howard Liang, CFO & Chief Strategy Officer at BeiGene, Ltd. (BGNE), sold 23,200 shares at $130.21 ($3.0M) on 2019-05-21, disclosed to the SEC on 2019-05-22.
Open-market sale of $3.0M BGNE by CFO & Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| BGNE | SELL | 2021-06-09 | $460K | — | Filing → |
| BGNE | SELL | 2021-01-19 | $9.6M | — | Filing → |
| BGNE | SELL | 2020-12-16 | $39.2M | — | Filing → |